Feasibility of modified docetaxel, oxaliplatin, capecitabine followed by capecitabine as maintenance chemotherapy as first-line therapy for patients with metastatic gastric or gastroesophageal cancer-Reference-Cited by-同舟云学术

Feasibility of modified docetaxel, oxaliplatin, capecitabine followed by capecitabine as maintenance chemotherapy as first-line therapy for patients with metastatic gastric or gastroesophageal cancer

Published:2020-03 Issue:3 Volume:31 Page:292-297
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Petrioli Roberto,Francini Edoardo,Cherri Sara,Marrelli Daniele,Rovello Franco,Fiaschi Anna Ida,Miano Salvatora Tindara,Savelli Vinno,Calomino Natale,Farsi Marco,Vernillo Remo,Francini Guido

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference21 articles.

1. Global cancer statistics.;Jemal;CA Cancer J Clin,2011

2. Pathological features as predictors of recurrence after radical resection of gastric cancer.;Buzzoni;Br J Surg,2006

3. Locally advanced and metastatic gastric cancer: current management and new treatment developments.;Field;Drugs,2008

4. Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 study group.;Van Cutsem;J Clin Oncol,2006

5. Docetaxel, cisplatin, and fluorouracil; docetaxel and cisplatin; and epirubicin, cisplatin, and fluorouracil as systemic treatment for advanced gastric carcinoma: a randomized phase II trial of the swiss group for clinical cancer research.;Roth;J Clin Oncol,2007

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Short- and Long-Term Advantages of Laparoscopic Gastrectomy for Elderly Patients with Locally Advanced Cancer;Cancers;2024-07-07

2. Can the Pathological Response in Patients with Locally Advanced Gastric Cancer Receiving Neoadjuvant Treatment Be Predicted by the CEA/Albumin and CRP/Albumin Ratios?;Journal of Clinical Medicine;2024-05-19

3. Peritoneal Metastatic Gastric Cancer: Local Treatment Options and Recommendations;Current Oncology;2024-03-09

4. Survival benefits of palliative gastrectomy for gastric cancer patients with liver metastasis: a population-based propensity score–matched cohort analysis;Frontiers in Oncology;2023-12-01

5. TOPBP1 regulates resistance of gastric cancer to oxaliplatin by promoting transcription of PARP1;DNA Repair;2022-03